1. Home
  2. SBFM vs TECH Comparison

SBFM vs TECH Comparison

Compare SBFM & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.12

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$50.86

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
TECH
Founded
2006
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
10.2B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SBFM
TECH
Price
$1.12
$50.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
12
Target Price
$7.00
$73.09
AVG Volume (30 Days)
33.8K
2.1M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
0.64%
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
N/A
$1,219,635,000.00
Revenue This Year
$10.26
$2.49
Revenue Next Year
$32.63
$6.40
P/E Ratio
N/A
$103.26
Revenue Growth
N/A
5.23
52 Week Low
$1.05
$46.02
52 Week High
$3.90
$72.16

Technical Indicators

Market Signals
Indicator
SBFM
TECH
Relative Strength Index (RSI) 45.51 35.65
Support Level $1.05 $48.93
Resistance Level $1.52 $54.08
Average True Range (ATR) 0.06 2.43
MACD 0.00 -0.43
Stochastic Oscillator 42.50 26.68

Price Performance

Historical Comparison
SBFM
TECH

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: